These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10334767)
1. Secondary prevention in coronary heart disease. Effects of statins have been in addition to those of aspirin and beta blockers. Morrell J BMJ; 1999 May; 318(7195):1419-20. PubMed ID: 10334767 [No Abstract] [Full Text] [Related]
2. [Methods of reporting research-results and their influence on decision-making by cardiologists prescribing drugs for primary and secondary prevention]. Brotons C; Moral I; Ribera A; Cascant P; Iglesias M; Permanyer-Miralda G; Ferreira González I; Soler-Soler J Rev Esp Cardiol; 2002 Oct; 55(10):1042-51. PubMed ID: 12383389 [TBL] [Abstract][Full Text] [Related]
3. Secondary prevention in coronary heart disease. Cost effectiveness of treatment must be borne in mind. Ferner RE BMJ; 1998 Dec; 317(7172):1592. PubMed ID: 9836677 [No Abstract] [Full Text] [Related]
4. National service framework for coronary heart disease. Ambiguities need to be clarified. Lloyd-Mostyn R BMJ; 2000 Sep; 321(7261):634. PubMed ID: 11023318 [No Abstract] [Full Text] [Related]
5. Secondary prevention may help intermittent claudication. Vass A; Leng G; Papacosta O; Walker M; Lennon L; Whincup PH BMJ; 2001 Mar; 322(7287):673. PubMed ID: 11250858 [No Abstract] [Full Text] [Related]
6. An editorial update: should she take aspirin? Mulrow C; Pignone M Ann Intern Med; 2005 Jun; 142(11):942-3. PubMed ID: 15941704 [No Abstract] [Full Text] [Related]
7. [Pharmacotherapy in the prevention of ischemic heart disease]. Metelitsa VI Kardiologiia; 1987 Jan; 27(1):5-10. PubMed ID: 2882045 [No Abstract] [Full Text] [Related]
8. [Secondary prevention of acute coronary syndromes: are we following correctly the guidelines?]. Casella G; Greco C; Maggioni AP; Di Pasquale G G Ital Cardiol (Rome); 2006 Mar; 7(3):176-85. PubMed ID: 16572983 [TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Aspirin for the prevention of heart attacks in people without previous cardiovascular events: recommendations from the United States Preventive Services Task Force. Ann Intern Med; 2002 Jan; 136(2):I55. PubMed ID: 11928737 [No Abstract] [Full Text] [Related]
11. Management of acute coronary syndromes. Schulman SP; Fessler HE Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971 [No Abstract] [Full Text] [Related]
12. Pharmacologic prevention of coronary artery disease. What do clinical trials show? Milani RV; Lavie CJ Postgrad Med; 1996 Feb; 99(2):109-12, 115-20. PubMed ID: 8632961 [TBL] [Abstract][Full Text] [Related]
13. [Primary prevention of coronary disease with drugs]. Capron L Rev Prat; 1998 Jun; 48(12):1281-2. PubMed ID: 9781183 [No Abstract] [Full Text] [Related]
14. Cost-effectiveness of statins added to aspirin therapy. Chelmowski MK Ann Intern Med; 2006 Aug; 145(3):233; author reply 233-4. PubMed ID: 16880474 [No Abstract] [Full Text] [Related]
15. Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants. Kendall MJ; Rajman I; Maxwell SR Postgrad Med J; 1994 May; 70(823):329-43. PubMed ID: 8016003 [No Abstract] [Full Text] [Related]
16. The primary prevention of coronary heart disease with statins: practice headache or public health? Evans PH Br J Gen Pract; 2000 Sep; 50(458):695-7. PubMed ID: 11050782 [No Abstract] [Full Text] [Related]